Snowball logo
logo
TAL

Taro Pharmaceutical Industries Ltd

TAL β€’ F
€40.00€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
669.9644.8549561.3573610.8
COGS
224.2245252.3268.2304.6317.6
Gross Profit
445.7399.7296.7293.1268.3293.3
Operating Expenses & Income
Operating Income
296.2246.5145.1124.917.7121.98
Total Operating Expenses
373.7398.2403.8436.4555.2588.9
R&D Expenses
63.2459.7860.1554.5452.2460.36
Selling General & Admin Expenses
89.9793.4191.36113.7198.4210.9
Earnings from Continuing Operations
Interest Expense
(0.256)(0.725)(1.363)(1.653)(1.253)-
Interest Income
19.6922.6620.178.18722.149.65
Income Tax Expense
74.7353.489.66719.59--
Net Income
Net Income
281.8244.2(386.7)58.2725.4545.7
Supplemental
EBIT
292.5246.5145.1124.9--
EBITDA
375.7320.1168.8150.849.84-
In millions of EUR, except % and values per 1 share